Aurobindo Pharma Ltd.
Share Price Target & Analysis
NSE:AUROPHARMA
VWAP
Open
Close
High
Low
52 Week High
-3.75 (-0.32%)
AUROPHARMA
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: AUROPHARMA Share Price Financial Analysis & Valuation
Aurobindo Pharma Ltd. (AUROPHARMA) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Large Cap company with Market Capitalization of Rs 35689.7 (in Cr). Total number of free float shares are 58.6 (in Lacs).
Aurobindo Pharma Ltd. is listed on NSE with Exchange ID - INE406A01037 and trading code is NSE:AUROPHARMA with short name Aurobindo Pharm.
Aurobindo Pharma Ltd. is a Good Quality Stock as it is listed in as TOP 50 Quality Picks by NSE. AUROPHARMA is having very good return on equity (ROE), financial leverage (Debt/Equity Ratio) and earning (EPS) growth variability analysed during the previous 5 years.
Aurobindo Pharma Ltd. is also traded in Future & Options (Derivative segment of NSE).
In the past 1 year, Aurobindo Pharma Ltd. has declared an equity dividend of Rs 4.5 per share. At the current share price of AUROPHARMA at Rs 1160.50, this results in a dividend yield of 0.39 %.
As per the Fundamental Analysis of NSE:AUROPHARMA, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine AUROPHARMA underlying value and future prospects. All of this data is available in AUROPHARMA financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:AUROPHARMA, it is clearly understood that AUROPHARMA is Economical performer in terms of earnings and profit margins with an EPS of 33.01. NSE:AUROPHARMA book value per share as of today is 338.43. The current price to book ratio for AUROPHARMA as of Mar 31, 2025 is 3.43.
Valuation of the Stock: The current valuation of AUROPHARMA stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of AUROPHARMA whether to BUY this stock at current valuation. The delivery percentage of AUROPHARMA is 38.81% is very crucial parameter which shows that 38.81% investors are anticipating that the price of AUROPHARMA share should go up with VWAP at 1163.55.
Now, the main question is whether to BUY or SELL, NSE:AUROPHARMA at current valuation.
As per latest Analysis No. #2163:-
⇑ STRONG BUY AUROPHARMA if All Greens
⇗ BUY AUROPHARMA (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD AUROPHARMA (With Stop Loss) if only 1 Green
⇘ SELL AUROPHARMA if NO Green Indicator
NSE: AUROPHARMA Share Price Today (Mar 31, 2025)
(Aurobindo Pharma Ltd. Daily Analysis on the basis of AUROPHARMA Intraday Graph & Trend)
Aurobindo Pharma Ltd. share price moved Down by -0.32% from its previous close of Rs 1164.25. AUROPHARMA stock last traded price is 1160.50. AUROPHARMA share price trend is Down with a total of 691447 stocks traded till now. It has touched an intraday high of Rs 1176 and an intraday low of Rs 1148.45. The AUROPHARMA trading at 1160.50, Down by Rs. -3.75, or -0.32 percent which suggests that most of the Traders are anticipating that the price of AUROPHARMA share should go Down.
NSE: AUROPHARMA Share Price Tomorrow Prediction
(Aurobindo Pharma Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of AUROPHARMA)
Aurobindo Pharma Ltd. share price moved Down by -0.32%. AUROPHARMA share price short term trend is Down. It suggests that AUROPHARMA Share Price for Tomorrow remains the same with VWAP at 1163.55 will be treated as stop loss for intraday traders. Aurobindo Pharma Ltd. Long term investors can follow the AUROPHARMA long term trend as mentiond in future forecast table.
NSE Code |
NSE: AUROPHARMA |
AUROPHARMA Share Price Today |
1160.50 |
AUROPHARMA Share Price Target Prediction for 2025 ^ |
1081 - 1391.9 |
AUROPHARMA Share Price Target Prediction for 2026*^ |
1391.9 - 1704.4 |
AUROPHARMA Share Price Target Prediction for 2027*^ |
1704.4 - 1823.7 |
AUROPHARMA Share Price Target Prediction for 2028*^ |
1915 |
AUROPHARMA Share Price Target Prediction for 2029*^ |
1970 |
AUROPHARMA Share Price Target Prediction for 2030*^ |
2147 |
AUROPHARMA Current Book Value 2024 |
336.7 |
*Aurobindo Pharma Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^AUROPHARMA share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
AUROPHARMA Technical Analysis
Candlestick Pattern: @1101.8MA | Simple | Action S1 | Expo | Action E2 |
---|---|---|---|---|
MA_5 | 1127.35 | SELL | 1122.68 | SELL |
MA_12 | 1151.58 | SELL | 1143.24 | SELL |
MA_20 | 1155.64 | SELL | 1154.81 | SELL |
MA_32 | 1168.58 | SELL | 1175.38 | SELL |
MA_50 | 1205.54 | SELL | 1197.81 | SELL |
MA_100 | 1249.8 | SELL | 1240.03 | SELL |
MA_200 | 1323.62 | SELL | 1246.51 | SELL |
Trend Oscillators | Value | Action |
---|---|---|
Bollinger Bands | 1101.82 | OverSold |
MACD | -3.46 | SELL |
ADX | 19.26 | NO or Weak Trend |
DMI (+/-) | 14.97 / 31.06 | Downtrend |
Momentum Oscillators | Value | Action |
---|---|---|
RSI | 38.24 | Neutral |
STOCHASTIC_K (Fast) | 44.3 | Neutral |
STOCHASTIC_D (Slow) | 48.44 | Neutral |
CCI | -116.89 | SELL |
PSAR | 1196.76 | SELL |
TRUE RANGE | 30.45 | SELL |
ATR | 44.54 | SELL |
WILLIAMS R | -70.63 | Neutral |
TRIX | 0 | Neutral |
STOCHASTIC RSI K | 0 | Oversold |
STOCHASTIC RSI D | 0 | Oversold |
MOMENTUM | -74.5 | SELL |
Duration | Value |
---|---|
1 Year | 5.23% |
3 Months | -11.27% |
1 Month | -6.33% |
1 Week | -5.8% |
Action | Overall (%) |
---|---|
BUY | 0% |
NEUTRAL / HOLD | 20% |
SELL | 80% |
Most popular Questions & Answers about AUROPHARMA
Aurobindo Pharma Ltd. stock last traded price is 1160.50. AUROPHARMA share price moved Down by -0.32% from its previous close of Rs 1164.25.
Aurobindo Pharma Ltd. share price trend is Down with a total of 691447 stocks traded till now. It has touched an intraday high of Rs 1607.92 and an intraday low of Rs 1148.45. The AUROPHARMA trading at 1160.50, Down by Rs. -3.75, or -0.32 percent which suggests that most of the Traders are anticipating that the price of AUROPHARMA share should go Down and the Stop Loss will be around 1163.55.
The market cap of Aurobindo Pharma Ltd. is ₹35689.7 (in Cr) as of Mar 30, 2025.
The current price to earning ratio for Aurobindo Pharma Ltd. as of Mar 30, 2025 is 46.1.
The current price to book ratio for Aurobindo Pharma Ltd. as of Mar 30, 2025 is 3.43.
The highest price of Aurobindo Pharma Ltd. stock is ₹1592 in the last 52-week.
The lowest price of Aurobindo Pharma Ltd. stock is ₹1031.05 in the last 52-week.
Aurobindo Pharma Ltd. share trading at ₹1160.50, Down by Rs. -3.75, or -0.32 percent which suggests that most of the traders are anticipating that the price of AUROPHARMA share should go Down.
In 2023, Stock price target for Aurobindo Pharma Ltd. (AUROPHARMA) are ₹1081 on downside and ₹1391.9 on upside. Aurobindo Pharma Ltd. share price target is based on current financial year earings of the company.
In 2024, Stock price target for Aurobindo Pharma Ltd. (AUROPHARMA) are ₹1391.9 on downside and ₹1704.4 on upside. Aurobindo Pharma Ltd. share price target is based on forecasted future earnings of the company.
In 2025, Stock price target for Aurobindo Pharma Ltd. (AUROPHARMA) are ₹1704.4 on downside and ₹1823.7 on upside. Aurobindo Pharma Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Aurobindo Pharma Ltd. (AUROPHARMA) will be around ₹1970 Aurobindo Pharma Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of AUROPHARMA.
The price of Aurobindo Pharma Ltd. (AUROPHARMA) shares moved by -0.32%. The short-term trend for AUROPHARMA share price is Down. It implies that the share price of AUROPHARMA will stay the same tomorrow and that intraday traders should treat VWAP at 1163.55 as a stop loss. Investors with a long-term outlook can track AUROPHARMA long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of AUROPHARMA stock is 395.8. Compared to the current market price of 1160.50 INR, the AUROPHARMA stock is Overvalued by 65.9%.
As per the fundamental analysis of Aurobindo Pharma Ltd. (AUROPHARMA), it is of Economical quality in terms of earnings and profit margins with an EPS of 33.01. Aurobindo Pharma Ltd. book value per share as of today is 338.43. The current price to book ratio for AUROPHARMA as of Mar 31, 2025 is 3.43.
NSE:AUROPHARMA News & Other Useful Information about AUROPHARMA Share Price
Peer Comparison of NSE: AUROPHARMA
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
Company | Price | EPS | BV |
---|---|---|---|
SUNPHARMA | 1734.70 | 13.13 | 98.33 |
DIVISLAB | 5775.45 | 78.09 | 513.62 |
MEDICAMEQ | 480.00 | 7.98 | 173.4 |
CIPLA | 1442.20 | 58.33 | 360.74 |
DRREDDY | 1144.20 | 62.12 | 322.46 |
PGHH | 15925.70 | 189.8 | 324.25 |
TORNTPHARM | 3227.95 | 53.89 | 222.38 |
BIOCON | 341.70 | 5.01 | 90.7 |
LUPIN | 2027.95 | 67.15 | 481.38 |
ALKEM | 4881.70 | 194.78 | 984.46 |